Category Archives: All member posts

Posts by IDSA and HIVMA members

The early days of a campus COVID-19 response: pivot and pivot again

By on .

By Lisa V. Adams, MD, and Kavita Kantamneni, MPH When Lisa describes her early days on Dartmouth’s COVID-19 response, she asks people to recall their “first COVID-19 moment,” that instant when they realized this was not a drill, that this was going to be something big and life-altering. For her, that was on Jan. 31, […]

Comments on key documents from the early weeks of SARS-CoV-2

By on .

By Daniel R. Lucey MD, MPH, FIDSA The purpose of this blog is to provide comments on reporting of some of the key COVID-19 events from 23 Chinese publications dated Dec. 31, 2019, until Feb. 17, 2021. Except for the five from the China CDC Weekly website, most are no longer online; however, I saved […]

Melioidosis cases in Georgia, Minnesota, Texas, Kansas “most closely related to strains found in Asia, particularly South Asia”: What is the epi-link?

By on .

By Daniel R. Lucey MD, MPH, FIDSA On Aug. 9, the U.S. Centers for Disease Control and Prevention reported both in their Health Alert Network and in a separate media statement a fourth case of melioidosis in the United States. This patient lived in Georgia and died in July 2021. The common exposure epidemiological (epi-) […]

Clues to COVID origins via Wuhan wet market study 2017-2019 of severe fever with thrombocytopenia syndrome

By on .

By Daniel R. Lucey MD, MPH, FIDSA Retrospective testing for SARS-CoV-2 virus and antibody could be (or has been) done using blood and other samples highly likely to have been obtained from the 18 mammalian species (including masked palm civet, racoon dogs, and mink) reported in the Wuhan wet markets, May 2017-November 2019, as part […]

Not until June 2021 does China report Wuhan wet markets sold palm civets, racoon dogs and mink from 2017-2019: Where are the SARS-CoV-2 results?

By on .

By Daniel R. Lucey MD, MPH, FIDSA Last month a paper titled “Animal sales from Wuhan wet markets immediately prior to the COVID-19 pandemic” by Xiao et al., in Nature Scientific Reports listed 18 mammalian species sold May 2017 -November 2019 in Wuhan wet markets (Table 1).  These mammalian species included masked palm civets (Paguma […]

Ghana kicks off Africa’s COVID-19 vaccine rollout

By on .

by Bertha Serwa Ayi, M.D., FACP, FIDSA, MBA With eyes tightly shut in anticipation of his injection, Dr. Frederick Kwarteng, Head of Department of the Orthopedics, Accident and Emergency at the Korlebu Teaching Hospital in Accra, Ghana became one of the first medical doctors in Africa to receive the first dose of COVISHIELD. Ghana became […]

Will survivors of variant P.1 have antibodies that also neutralize B.1.351 — and vice versa?

By on .

By Daniel R. Lucey MD, MPH, FIDSA The SARS-CoV-2 variants first described in Manaus, Brazil “P.1.” and in South Africa “B.1.351” share at least five mutations including the antibody-evading changes at amino acids 484 and 417 in the spike protein. Potential cross-protection against the P.1 variant by the new Moderna-NIH B1.351 variant vaccine has been […]

Russia shared sequence of mutated H5N8 flu infecting humans with GISAID: Will other nations also develop human tests and vaccines?

By on .

By Daniel R. Lucey MD, MPH, FIDSA The Russian News Agency TASS reported on Feb. 20  that Russia had shared the genetic sequence of the mutated H5N8 avian influenza viruses that in December infected seven minimally symptomatic poultry farm workers in Astrakhan, southern Russia. The Global Initiative on Sharing Avian Influenza Data (GISAID) is the […]